VC  Foresite Capital

http://www.foresitecapital.com





     Office Locations:

900 Larkspur Landing Circle Suite 150
Larkspur, CA 94939
Phone: 415-877-4887
Fax: 415-567-0091

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Expansion


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Foresite Capital invests between $10 million and $50 million per investment in emerging healthcare companies with disruptive late-stage products with large market opportunities in therapeutics, devices, diagnostics, and services. Since inception in 2011, Foresite has invested in more than 11 transformative companies spanning therapeutics, devices and diagnostics. In April of 2014, the firm announced the closing of Foresite Capital Fund II, which was oversubscribed and closed with $300 million in capital commitments. Fund II follows Foresite Capital Fund I, a $100 million fund that closed in January 2013. Foresite Capital has $3.5 billion in assets under management.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Amelia Stoj CCO and Assistant General Counsel
    Dennis D. Ryan MBA, CPA CFO & Managing Director
    Dorothy Margolskee MD Managing Director
    Jim Tananbaum MD Founder & CEO
    Shannon Bergstedt Principal & Venture Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/12/2024


      Pleno


      CA


      $25,000,000


      Series B


      12/05/2024


      Sollis Health


      NY


      $33,000,000


      Series B


      12/03/2024


      Maze Therapeutics


      CA


      $115,000,000


      Series D


      11/07/2024


      Seaport Therapeutics


      MA


      $225,000,000


      Series B


      07/29/2024


      Spear Bio


      MA


      $45,000,000


      Series A


      07/23/2024


      Third Arc Bio


      MA


      $165,000,000


      Series A


      07/16/2024


      Thyme Care


      TN


      $95,000,000


      Series C


      07/11/2024


      Element Biosciences


      CA


      $277,000,000


      Series D


      04/03/2024


      Obsidian Therapeutics


      MA


      $160,500,000


      Series C


      03/06/2024


      Alumis


      CA


      $259,000,000


      Series C


     

    Portfolio companies include:


      10X Genomics
        web link


      Adagio Therapeutics
        web link


      Aduro BioTech
        web link


      Aetion
        web link


      Alumis
        web link


      Arcus Biosciences
        web link


      AveXis


      Cerevance
        web link


      Cue


      Decibel Therapeutics
        web link


      Delfi Diagnostics
        web link


      DNAnexus
        web link


      Element Biosciences
        web link


      EverlyWell
        web link


      Folx Health
        web link


      Foresight Diagnostics
        web link


      Genapsys
        web link


      Generation Bio
        web link


      Inscripta
        web link


      Insitro
        web link


      Intarcia Therapeutics
        web link


      Intellia Therapeutics
        web link


      Interline Therapeutics
        web link


      Ivantis
        web link


      Jounce Therapeutics
        web link


      Kinnate Biopharma
        web link


      Kriya
        web link


      LifeMine Therapeutics
        web link


      Maze Therapeutics
        web link


      Mindstrong Health
        web link


      Muse Bio
        web link


      Nested Therapeutics
        web link


      Nurix Therapeutics
        web link


      Obsidian Therapeutics
        web link


      Olema Oncology
        web link


      Orchard Therapeutics


      ORIC Pharmaceuticals


      Peloton Therapeutics
        web link


      Pleno
        web link


      REGENXBIO
        web link


      Relay Therapeutics


      Replimune
        web link


      Seaport Therapeutics
        web link


      Sollis Health
        web link


      Spear Bio
        web link


      SutroVax
        web link


      Tasso
        web link


      Tempest Therapeutics
        web link


      TenSixteen Bio
        web link


      Theseus Pharmaceuticals
        web link


      Third Arc Bio
        web link


      Thyme Care
        web link


      VenatoRx Pharmaceuticals
        web link


      WaVe Life Sciences
        web link


     

    Recent News: